FeraSafe Consortium

Our lab is hosting the multi-center FeraSafe Safety Registry study.

FeraSafe aims to investigate the use of Ferumoxytol, an FDA-approved molecule traditionally used to treat anemia, as a contrast agent for MRI. We have been evaluating the use of this agent for over 10 years to enhance cardiac imaging while prioritizing patient safety.